A review of hypofractionated palliative radiotherapy

Cancer

Volumn 109, Issue 8, 2007, Pages 1462-1470

  Lutz, Stephen T ^a   Chow, Edward L ^b   Hartsell, William F ^c   Konski, Andre A ^d  

^a Blanchard Valley Regional Cancer Center   (United States)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c Advocate Good Samaritan Hospital   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Hypofractionation; Palliation; Radiotherapy; Symptom control

Indexed keywords

BLADDER CANCER; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RECTUM CANCER; REVIEW; SPLEEN CANCER; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

DOSE FRACTIONATION; HUMANS; NEOPLASMS; PALLIATIVE CARE; RADIATION ONCOLOGY;

EID: 34247178416     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22555     Document Type: Review

References (65)

1. Coutard H. Principles of x-ray therapy of malignant diseases. Lancet. 1934;2:1-8.
2. Coia L, Hanks G, Martz K, et al. Practice patterns of palliative care for the United States 1984-1985. Int J Radiat Oncol Biol Phys. 1988;14:1261-1269.
3. Janjan NA. An emerging respect for palliative care in radiation oncology. J Palliative Med. 1988;1:83-88.
4. Lutz S, Spence C, Chow E, et al. Survey on utilization of palliative radiotherapy in hospice care. J Clin Oncol. 2004;22:3581-3586.
5. Lutz S, Ashworth J, Spence C, et al. The use of radiotherapy in hospice and radiotherapy patients: a population-based study from the National Hospice Outcomes Project [abstract]. J Clin Oncol. 2005;23(16S)8074.
6. Amadeo A.Radiation oncology in palliative care: survey of US physicians. Special panel presentation - Palliative Radiotherapy: Cost, Utilization, and Efficacy. National Meeting of the American Society for Therapeutic Radiology and Oncology, October 21, 2003, Salt Lake City, Utah.
7. Price P, Hoskin P, Easton D, et al. Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986;6:247-255.
8. Cole D. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bony metastases. Clin Oncol (R Coll Radiol). 1989;1:59-62.
9. Hoskin P, Price P, Easton D, et al. A prospective randomized trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol. 1992;23:74-78.
10. Gaze M, Kelly C, Kerr G, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomized trial of two fractionation schedules. Radiother Oncol. 1997;45:109-116.
11. Nielsen O, Bentzen S, Sandberg E, et al. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastasis. Radiother Oncol. 1998;47:233-240.
12. Jeremic B, Shibamoto Y, Acimovic L, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys. 1998;42:161-167.
13. Steenland E, Leer J, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999;52:101-109.
14. Yarnold J. Eight-Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with a multifraction schedule over 12 months of patient follow-up. On behalf of the Bone Pain Trial Working Party. Radiother Oncol. 1999;52:111-121.
15. Kirkbride P, Warde P, Panzarella A, Aslanidis J. A randomized trial comparing the efficacy of single fraction radiation therapy plus ondansetron with fractionated radiation therapy in the palliation of skeletal metastases. Int J Radiat Oncol Biol Phys. 2000;48(suppl 3):185. Abstract 147.
16. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of bone metastases. J Natl Cancer Inst. 2005;97:798-804.
17. Roos D, Turner S, O'Brien P, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol. 2005; 75:54-63.
18. Wu JSY, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastasis. Int J Radiat Oncol Biol Phys. 2003;55:594-605.
19. Kaasa S, Brenne E, Lund J, et al. Prospective randomized multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol. 2006;79:278-284.
20. Van den Hout W, van der Linden Y, Steenland E, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost utility analysis based on a randomized trial. J Natl Cancer Inst. 2003;95:222-229.
21. Konski A. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys. 2004;60:1373-1378.
22. Macklis R, Cornelli H, Lasher J. Brief course of palliative radiotherapy for metastatic bone pain: a pilot cost-minimization comparison with narcotic analgesics. Am J Clin Oncol. 1998;21:617-622.
23. Simpson J, Francis M, Perez-Tamayo R, Marks RD, Rao DV. Palliative radiotherapy for inoperable carcinoma of the lung: final report of the RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys. 1985;11:751-758.
24. Teo P, Tai PH, Choi D, et al. A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1988;14: 867-871.
25. Medical Research Council. Inoperable non-small cell lung cancer (NSCLC): a Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer. 1991;63:265-270.
26. Medical Research Council. A Medical Research Council randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer and poor performance status. Br J Cancer. 1992;65:934-941.
27. Abratt RP, Shepherd LJ, Salton DG. Palliative radiation for stage 3 non-small cell lung cancer - a prospective study of two moderately high dose regimens. Lung Cancer. 1995;13: 137-143.
28. Macbeth FR, Bolger JJ, Bailey AJ, et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Br J Cancer. 1996;65:934-941.
29. Rees FJ, Devrell CE, Newman HF, et al. Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol (R Coll Radiol). 1997;9:90-95.
30. Plataniotis GA, Kouvaris JR, Vlahos L, et al. A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC): effective palliation and patients' convenience. Lung Cancer. 2002;35:203-207.
31. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Cancer Treat Rev. 2003;29:123-125.
32. Sundstrom S, Bremnes R, Aasebo U, et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol. 2004;22:765-768.
33. Kramer GW, Wanders SL, Noordijk EM, et al. Results of the Dutch national study of the palliative effects of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol. 2005;23:2962-2970.
34. Senkus-Konefka E, Dziadziuszko R, Bednaruk-Mynski E, et al. A prospective, randomized study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer. 2005;92:1038-1045.
35. Stevens MJ, Beqbie SD. Hypofractionated radiation for inoperable non-small lung cancer. Australas Radiol. 1995; 39:265-270.
36. Vyas RK, Suryanarayana U, Baboo HA, et al. Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions. Indian J Chest Dis Allied Sci. 1998;40:171-174.
37. Donato V, Zurlo A, Bonfili P, et al. Hypofractionated radiation therapy for inoperable advanced non-small cell lung cancer. Tumori. 1999;85:174-176.
38. Bhatt ML, Mohani BK, Kumar L, et al. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy. Indian J Cancer. 2000;37:148-152.
39. Lupattelli M, Maranzano E, Bellavita R, et al. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study. Am J Clin Oncol. 2000;23:83-93.
40. Cross CK, Berman S, Buswell L, et al. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1098-1105.
41. Rodrigues CI, Njo KH, Karim AB. Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer. 1993;10:221-228.
42. Spanos WJ, Wasserman T, Moez R, et al. Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study. Int J Radiat Oncol Biol Phys. 1987;13:1479.
43. Halle JS, Rosenman JG, Varia MA, Fowler WC, Walton LA, Currie JL. 1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium. Int J Radiat Oncol Biol Phys. 1986;12:1947-1950.
44. Spanos W, Guse C, Perez C, et al. Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502. Int J Radiat Oncol Biol Phys. 1989;17:659-661.
45. Spanos WJ, Perez CA, Marcus S, et al. Effect of rest interval on tumor and normal tissue response - a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502). Int J Radiat Oncol Biol Phys. 1993;25:399.
46. Kynaston HG, Keen CW, Matthews PN. Radiotherapy for palliation of locally advanced carcinoma. Br J Urol. 1990; 66:515-517.
47. Janjan NA, Breslin T, Lenzi R, et al. Avoidance of colostomy placement in advanced colorectal cancer with twice weekly hypofractionated radiation plus continuous infusion 5-fluorouracil. J Pain Symptom Manage. 2000;20:266-272.
48. Wong R, Thomas G, Cummings B, et al. The role of radiotherapy in the management of pelvic recurrence of rectal cancer. Can J Oncol. 1996;6(suppl 1):39-47.
49. McLaren DB, Morrey D, Mason MD. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol. 1997;43:171-174.
50. Jose CC, Price A, Norman A, et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin Oncol (R Coll Radiol). 1999;11:330-333.
51. Scholten AN, Leer JW, Collins CD, et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol. 1997;43:163-169.
52. Srinivasan V, Brown CH, Turner AG. A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. Clin Oncol (R Coll Radiol). 1994;6:11-13.
53. Duchesne GM, Bolger JJ, Griffiths GO, et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of a Medical Research Council trial BA09. Int J Radiat Oncol Biol Phys. 2000;47:379-388.
54. Weissberg JB, Pillsbury H, Sasaki CT, et al. High fractional dose irradiation of advanced head and neck cancer. Implications for combined radiotherapy and surgery. Arch Otolaryngol. 1983;109:L98-L102.
55. Corry J, Peters LJ, Costa ID, et al. The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol. 2005;77:137-142.
56. Mohanti BK, Umapathy H, Bahadur S, et al. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol. 2004;71:275-280.
57. Paulino AC, Reddy SP. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Am J Hosp Palliat Care 1996;13:32-35.
58. McFarland JT, Kuzma C, Millard FE, Johnstone PA. Palliative irradiation of the spleen. Am J Clin Oncol. 2003;26: 178-183.
59. Hassett M, O'Malley J, Pakes J, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst. 1998;16:1108-1117.
60. Center for the Evaluative Clinical Sciences at Dartmouth Medical School.The care of patients with severe chronic illness: an online report of the Medicare program by the Dartmouth Atlas Project. The Dartmouth Atlas of Health Care 2006. Available at URL: http://www.dartmouthatlas. org/atlases/ 2006_Chronic_Care_Atlas.pdf Accessed November 29, 2006.
61. Schrag D. The price tag on progress - chemotherapy for colorectal cancer. N Engl J Med. 2004;351:317-319.
62. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Update to the hospice payment rates. Available at URL: http://www.cms.hhs.gov/transmittals/downloads/R1094CP.pdf Accessed November 29, 2006.
63. Leibel S, Fuks Z, Zelefsky M, et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol. 2003;30:596-615.
64. Pollack A, Hanlon A, Horwitz E, et al. Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World J Urol. 2003;21:200-208.
65. American Board of Hospice and Palliative Medicine.ABMS votes to make Hospice and Palliative Medicine an ABMS subspecialty. Available at URL: http://www.abhpm.org/gfxc_119.aspx. Accessed November 29, 2006.